Dimerix Limited (ASX:DXB)
Australia · Delayed Price · Currency is AUD 0.2150
-0.0050 (-2.27%)
Nov 11, 2026, 4:10 PM AEDT
Dimerix Market Cap
Dimerix has a market cap or net worth of 129.09 million as of November 10, 2026. It is the 25,804th most valuable company in the world and the 551st biggest in Australia. Its market cap has decreased by 55.21% in one year.
Market Cap
129.09M
Enterprise Value
113.16M
Revenue
6.35M
Global Rank
Country Rank
#551 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since July 6, 2015, Dimerix's market cap has increased from 13.24M to 129.09M, an increase of 875.23%. That is a compound annual growth rate of 22.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 129.09M | -60.91% |
| Dec 31, 2025 | 330.22M | 74.10% |
| Dec 31, 2024 | 189.67M | 117.15% |
| Dec 29, 2023 | 87.35M | 87.74% |
| Dec 30, 2022 | 46.53M | -40.82% |
| Dec 31, 2021 | 78.61M | 69.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BLS Pharmaceuticals | 208.43M |
| Starpharma Holdings | 196.69M |
| Actinogen Medical | 186.62M |
| Orthocell | 164.80M |
| Paradigm Biopharmaceuticals | 153.48M |
| Nyrada | 115.13M |
| Recce Pharmaceuticals | 105.49M |
| Island Pharmaceuticals | 90.31M |